✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Vilin Bio Med Ltd.

VILINBIO

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹35 Cr.
P/E
156.35

Vilin Bio Med Ltd.

  • Vilin Bio Med
  • iStreet Network
  • Veerhealth Care
FAQs on Vilin Bio Med Ltd. Shareprice

Vilin Bio Med has given better returns compared to its competitors.
Vilin Bio Med has grown at ~4.48% over the last 2yrs while peers have grown at a median rate of -1.21%

Yes, Vilin Bio Med is expensive.
Latest PE of Vilin Bio Med is 156, while 3 year average PE is 120.
Also latest EV/EBITDA of Vilin Bio Med is 174 while 3yr average is 48.44.

View FAQ's On Business
Growth Table
  • Vilin Bio Med Ltd.
  • iStreet Network
  • Veerhealth Care
Balance Sheet
  • Vilin Bio Med Ltd.
  • iStreet Network
  • Veerhealth Care
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vilin Bio Med Ltd.
  • iStreet Network
  • Veerhealth Care
Cash Flow
  • Vilin Bio Med Ltd.
  • iStreet Network
  • Veerhealth Care
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vilin Bio Med Ltd.
  • iStreet Network
  • Veerhealth Care
Quarterly Results
  • Vilin Bio Med Ltd.
  • iStreet Network
  • Veerhealth Care
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Vilin Bio Med Ltd. Financials

Balance sheet of Vilin Bio Med is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Vilin Bio Med is increasing.
Latest net debt of Vilin Bio Med is ₹2.52 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹5.22 Crs.

The profit is oscillating.
The profit of Vilin Bio Med is ₹0.22 Crs for Mar 2025, ₹0.16 Crs for Mar 2024 and ₹1.25 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vilin Bio Med latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech